9.5
1K+ Ratings
American Society for Colposcopy and Cervical Pathology Inc
Developer
43.3 MB
Size
11/10/2024
Update Date
#6
in Medical
17+
Age Rating
Age Rating
لقطات الشاشة لـ ASCCP Management Guidelines
About ASCCP Management Guidelines
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
Show More
تحديث لأحدث إصدار 2.0.1
Last updated on 11/10/2024
الإصدارات القديمة
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
Show More
Version History
2.0.1
11/10/2024
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
2.0
10/10/2024
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
1.7
24/02/2022
Recommendation updates based on new erratum publication.
1.6
25/11/2021
Minor improvements to management recommendations and typographical errors
1.5
24/09/2021
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.
Expanded app to include Screening Guidelines.
1.3
09/04/2021
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.2
01/10/2020
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.1
19/08/2020
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.
1.0
05/06/2020
سعر ASCCP Management Guidelines
اليوم:
USD 14.99
أقل سعر:
USD 9.99
أعلى سعر:
USD 14.99
ASCCP Management Guidelines FAQ
انقر هنا لمعرفة كيفية تنزيل ASCCP Management Guidelines في بلد أو منطقة محظورة.
تحقق من القائمة التالية لمعرفة الحد الأدنى من المتطلبات ASCCP Management Guidelines.
iPhone
Requiere iOS 11.2 o posterior.
iPad
Requiere iPadOS 11.2 o posterior.
iPod touch
Requiere iOS 11.2 o posterior.
ASCCP Management Guidelines هي مدعومة على اللغات Inglés